Please login to the form below

Not currently logged in
Email:
Password:

Anders Spohr appointed executive VP for global product supply at Leo Pharma

Former senior VP takes over from John Mehlbye

Leo Pharma has promoted current senior VP Anders Spohr to the position of executive VP for global product supply.

On March 1, 2012, Spohr will take over from John Mehlbye at the Denmark-based pharma firm, with Mehlbye to continue on the board of directors of the Leo Foundation, which owns Leo Pharma.

Spohr only joining Leo Pharma in December, moving from Danish biotech Novozymes where he spent 11 years, serving as vice president of enzymes business supply chain management, production director for Novozymes North America and director of product and technology co-ordination.

Previously, Spohr worked at Novo Nordisk from 1997 to 2000, before Novozymes separated from Novo Nordisk to become its own independent company.

In his new role at Leo, he will have responsibility for ensuring flexible, efficient and streamlined production processes to support the pharma company's operations in more than 100 countries.

28th February 2012

Share

Subscribe to our email news alerts

PMHub

Add my company
Red Thread

Blending brilliant writing with in-depth market access and reimbursement expertise...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....